列线图在孤立性亚实性肺结节中鉴别微浸润与浸润性腺癌
回顾性纳入100例病理确诊的亚实性肺结节患者(微浸润腺癌43例,浸润性腺癌57例),从CT图像提取影像组学特征构建影像组学标签,并结合实性成分、病灶大小、形状规则性和边缘等主观征象建立影像组学列线图。列线图在训练集AUC 0.943(95%CI 0.895-0.991)、验证集AUC 0.912(95%CI 0.780-1.000),校准和决策曲线分析显示临床有用。
要点
- 影像组学列线图在训练集AUC 0.943、验证集AUC 0.912,可用于术前鉴别微浸润与浸润性腺癌。
- 列线图整合了11个影像组学特征与实性成分、病灶大小、形状规则性、边缘等CT主观征象。
- 决策曲线分析显示列线图具有临床实用性。
核心结论
- 所提出的影像组学列线图有潜力在术前鉴别亚实性肺结节患者的微浸润腺癌与浸润性腺癌。
研究设计与样本
- 回顾性研究,共纳入100例亚实性肺结节患者,其中微浸润腺癌43例(男13例、女30例),浸润性腺癌57例(男26例、女31例),从CT图像提取影像组学特征,以LASSO算法构建影像组学标签,结合CT主观征象构建列线图,并评估校准、区分度和临床实用性。
关键影像表现/征象
- 评估的CT主观征象包括实性成分、病灶大小、形状规则性和边缘。
- 影像组学标签由11个影像组学特征组成,显示出良好的区分准确度。
诊断标准与关键数值
- 影像组学列线图训练集AUC 0.943(95%CI 0.895-0.991)。
- 影像组学列线图验证集AUC 0.912(95%CI 0.780-1.000)。
- 决策曲线分析确定影像组学列线图具有临床实用性。
临床应用与阅片要点
- 影像组学列线图有潜力用于术前鉴别亚实性肺结节的微浸润腺癌与浸润性腺癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the preoperative differentiation between the minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) in patients with sub-solid pulmonary nodules using a radiomics nomogram.
MATERIALS AND METHODS: A total of 100 patients with sub-solid pulmonary nodules who had pathologically confirmed MIA (43 patients, 13 male and 30 female) or IAC (57 patients, 26 male and 31 female) were recruited retrospectively. Radiomics features were extracted from computed tomography (CT) images. A radiomics signature was constructed by the least absolute shrinkage and selection operator (LASSO) algorithm. Solid presence, lesion size, shape regularity, and margins of pulmonary nodules were assessed to construct a subjective finding model. An integrated model of radiomics signatures and CT-based subjective findings, which was presented as a radiomics nomogram, was developed based on a multivariate logistic regression. The nomogram performance was assessed by its calibration, discrimination, and clinical usefulness.
RESULTS: The radiomics signature, which consisted of 11 radiomics features, showed good discrimination accuracy. The radiomics nomogram showed good calibration and discrimination in the training set (AUC [area under the curve] 0.943; 95% confidence interval [CI]: 0.895-0.991) and validation set (AUC 0.912; 95% CI: 0.780-1.000). The radiomics nomogram was determined to be clinically useful in the decision curve analysis (DCA).
CONCLUSION: The proposed radiomics nomogram has the potential to preoperatively differentiate MIA and IAC in patients with sub-solid pulmonary nodules.
引用
- Feng B, Chen X, Chen Y, et al. Differentiating minimally invasive and invasive adenocarcinomas in patients with solitary sub-solid pulmonary nodules with a radiomics nomogram. Clin Radiol. 2019. PMID: 31056198. doi:10.1016/j.crad.2019.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。